Tag Archives: REGN

J.P. Morgan Sticks to Their Hold Rating for Regeneron (REGN)

J.P. Morgan analyst Cory Kasimov maintained a Hold rating on Regeneron (REGN – Research Report) yesterday and set a price target of $375.00. The company’s shares closed last Monday at $332.60. According to TipRanks.com, Kasimov is a 4-star analyst with

Tuesday’s Midday Stock Update: Kroger Company (KR), Amarin (AMRN), Karyopharm Therapeutics (KPTI), Regeneron (REGN), Agios Pharma (AGIO)

So far Tuesday, November 5, NASDAQ is down -0.39% and the S&P is down -0.67%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Kroger Company (KR – Research Report), Amarin (AMRN – Research

Regeneron (REGN) Gets a Hold Rating from Canaccord Genuity

In a report released today, John Newman from Canaccord Genuity maintained a Hold rating on Regeneron (REGN – Research Report), with a price target of $320.00. The company’s shares closed last Monday at $285.10, close to its 52-week low of

Regeneron (REGN) Gets a Hold Rating from Cowen & Co.

Cowen & Co. analyst Yaron Werber maintained a Hold rating on Regeneron (REGN – Research Report) today and set a price target of $353. The company’s shares closed on Friday at $309.18, close to its 52-week low of $287.66. According

Cowen & Co. Reaffirms Their Hold Rating on Regeneron (REGN)

In a report released today, Yaron Werber from Cowen & Co. maintained a Hold rating on Regeneron (REGN – Research Report), with a price target of $353. The company’s shares opened today at $333. According to TipRanks.com, Werber is a

The President & CEO of Regeneron is Exercising Options

Today it was reported that the President & CEO of Regeneron (REGN – Research Report), Leonard Schleifer, exercised options to buy 100 REGN shares at $21.25 a share, for a total transaction value of $2,125. Following Leonard Schleifer’s last REGN